Streetbeat News

Analyst Ratings

FATE

Mizuho analyst Mara Goldstein has maintained a Buy rating on Fate Therapeutics (NASDAQ:FATE) but reduced the price target from $12 to $8.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 3:48 pm

TSLA

Jefferies analyst Philippe Houchois has maintained a Hold rating on Tesla (NASDAQ:TSLA) but reduced the price target from $250 to $210.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 3:43 pm

LPTX

Mizuho analyst Mara Goldstein has maintained a Buy rating on Leap Therapeutics (NASDAQ:LPTX) but has reduced the price target from $20 to $12.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 3:40 pm

ALC

Jefferies analyst Anthony Petrone has maintained a Buy rating on Alcon (NYSE:ALC) but has reduced the price target from $94 to $88.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 3:39 pm

NJR

Mizuho analyst Gabriel Moreen has maintained a Neutral rating on New Jersey Resources (NYSE:NJR) but has lowered the price target from $49 to $47.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 3:36 pm

FIVN

Piper Sandler analyst James Fish has maintained an Overweight rating on Five9 (NASDAQ:FIVN) and increased the price target from $77 to $84.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 3:35 pm

ADCT

HC Wainwright & Co. analyst Robert Burns has maintained a Buy rating on ADC Therapeutics (NYSE:ADCT) but has significantly lowered the price target from $12 to $3.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 3:31 pm

WLK

Piper Sandler analyst Charles Neivert has maintained an Overweight rating on Westlake (NYSE:WLK) and increased the price target from $144 to $150.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 3:31 pm

SWIM

Stifel analyst W. Andrew Carter has maintained a Hold rating on Latham Group (NASDAQ:SWIM) but has reduced the price target from $4.85 to $3.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 3:28 pm

SR

Stifel analyst Selman Akyol has maintained a Hold rating on Spire (NYSE:SR) but has reduced the price target from $67 to $64.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 3:25 pm